Price Alert

Scinai Immunotherapeutics... (SCNI)

NASDAQ: SCNI · Real-Time Price · USD

1.69

0.16 (10.10%)

At close: Aug 21, 2025, 2:50 PM

Scinai Immunotherapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	1.03M	3.08M	4.83M	4.87M	6.36M	7.51M	10.8M	14.07M	8.26M	11.29M	15.28M	17.37M	10.75M	12.23M	14.53M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	271.46K	277.06K	290.38K	n/a	138.33K	134.03K	130.39K
Receivables	120K	119K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	137K	138K	140K	506K	122K	126K	127K	250K	199.95K	178.99K	193.49K	241K	442.29K	810K	143.85K
Total Current Assets	1.62M	3.66M	5.25M	5.45M	6.71M	7.77M	11.04M	14.37M	8.46M	11.47M	15.47M	17.84M	11.2M	13.04M	14.67M
Property-Plant & Equipment	10.64M	11.19M	11.8M	12.03M	11.87M	12.13M	12.25M	12.7M	12.22M	12.72M	14.1M	14.19M	13.8M	13.83M	13.53M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	10.64M	11.19M	11.8M	12.03M	11.87M	12.13M	12.25M	12.7M	12.5M	12.99M	14.39M	14.19M	13.93M	13.96M	13.66M
Total Assets	12.26M	14.85M	17.05M	17.47M	18.58M	19.9M	23.29M	27.07M	20.95M	24.47M	29.86M	32.04M	25.13M	27M	28.33M
Account Payables	430K	658K	928K	535K	546K	651K	1.31M	716K	295.58K	588.13K	1.28M	999K	1.03M	808.16K	623.54K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	242.01K	5.35M	n/a	n/a	20M	19.7M	18.65M
Other Current Liabilities	598K	650K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	2.00	2.00	2.00
Total Current Liabilities	1.39M	1.67M	1.93M	1.78M	1.54M	1.89M	2.58M	2.34M	1.47M	6.72M	2.66M	2.44M	21.8M	21.28M	19.95M
Long-Term Debt	280K	19.82M	19.51M	19.37M	18.6M	23.29M	21.85M	20.08M	15.53M	14.85M	20.38M	27.16M	n/a	n/a	n/a
Other Long-Term Liabilities	3K	3K	n/a	96K	311K	902K	2.66M	5.33M	26.64K	27.16K	29.7K	n/a	205.64K	377.24K	367.85K
Total Long-Term Liabilities	866K	20.46M	20.24M	20.26M	19.74M	25.12M	25.52M	26.49M	16.86M	16.46M	22.15M	28.61M	2.04M	2.23M	2.16M
Total Liabilities	2.26M	22.14M	22.17M	22.04M	21.27M	27.01M	28.1M	28.83M	18.33M	23.19M	24.81M	31.05M	23.83M	23.51M	22.11M
Total Debt	1.23M	20.82M	20.63M	20.56M	19.81M	24.61M	23.28M	21.54M	17.39M	22.03M	22.37M	28.98M	22.07M	21.79M	20.62M
Common Stock	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Retained Earnings	-115.31M	-126.82M	-124.49M	-122.33M	-120M	-123.11M	-119.35M	-115.83M	-107.49M	-110.66M	-116.96M	-110.04M	-109.8M	-105.8M	-99.58M
Comprehensive Income	-1.74M	-1.74M	-1.74M	-1.74M	-1.74M	-1.74M	-1.89M	-2.01M	n/a	n/a	-0.00	-2.06M	n/a	n/a	n/a
Shareholders Equity	10M	-7.28M	-5.12M	-4.57M	-2.69M	-7.11M	-4.81M	-1.76M	2.62M	1.28M	5.05M	982K	1.3M	3.49M	6.22M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a